Bionano Genomics (BNGO) Current Deferred Revenue (2017 - 2026)
Bionano Genomics (BNGO) posted Current Deferred Revenue of $1.1 million for Q1 2026, up 16.44% sequentially from $967000.0 in Q4 2025, and up 10.39% YoY from $1.0 million in Q1 2025.
Bionano Genomics (BNGO) Current Deferred Revenue (2017 - 2026) Analysis & Trends
Bionano Genomics has reported Current Deferred Revenue for 10 years, with the latest figure at $1.1 million in Q1 2026.
- Quarterly Current Deferred Revenue rose 10.39% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 10.39% YoY) and the FY2025 annual result came in at $967000.0, down 14.27% from the prior year.
- Current Deferred Revenue advanced to $1.1 million in Q1 2026 per BNGO's latest filing, from $967000.0 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $1.2 million in Q3 2024 and troughed at $783000.0 in Q4 2023.
- A 5-year average of $1.0 million and a median of $1.1 million in 2022 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2022 and 2023: Current Deferred Revenue soared 267.77% in 2022, then dropped 17.12% in 2023.
- Over 5 years, Current Deferred Revenue stood at $871000.0 in 2022, then declined by 10.1% to $783000.0 in 2023, then soared by 44.06% to $1.1 million in 2024, then retreated by 14.27% to $967000.0 in 2025, then climbed by 16.44% to $1.1 million in 2026.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $1.1 million, $967000.0, and $1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Bionano Genomics | 13.74 Mn | 3.81 Mn | 4.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.15 Mn |
| Mar 31, 2026 | 1.13 Mn |
| Dec 31, 2025 | 967,000.00 |
| Sep 30, 2025 | 1.18 Mn |
| Jun 30, 2025 | 1.17 Mn |
| Mar 31, 2025 | 1.02 Mn |
| Dec 31, 2024 | 1.13 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 1.15 Mn |
| Mar 31, 2024 | 1.04 Mn |
| Dec 31, 2023 | 783,000.00 |
| Sep 30, 2023 | 811,000.00 |
| Jun 30, 2023 | 978,000.00 |
| Mar 31, 2023 | 1.13 Mn |
| Dec 31, 2022 | 871,000.00 |
| Sep 30, 2022 | 976,000.00 |
| Jun 30, 2022 | 1.18 Mn |
| Mar 31, 2022 | 1.11 Mn |
| Dec 31, 2021 | 684,000.00 |
| Sep 30, 2021 | 411,000.00 |